Endometrial Cancer and Chemical Hair Relaxers

CALL 24/7(888) 348-2735

Hair Relaxer Lawsuit — Free, Confidential Consultation

Endometrial cancer is uterine cancer — and it is on the trial track.

Same lawsuit, same one question. Two confidential minutes, an honest answer either way.

Active litigation — no settlement. MDL 3060 underway · 12,381 cases pending · filing deadlines vary by state and run from when you knew or should have known.

Did you get relaxers — perms, the white cream — every few weeks, for years?

That one question decides most of it. It seems like nobody ever told you the risk was anything worse than a scalp burn.

See where I standfree · confidential · 2 minutes · an honest answer either way
What the lawsuit is actually about →

No receipts needed · you don’t have to remember every brand · no fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

Or talk to a person now: (888) 348-2735 — answered 24/7

Marin & Murphy Law Firm

Every inquiry gets a personal review and a straight answer — including “not yet” or “no” — free and without obligation.

Claims are brought against the companies that made and sold chemical relaxers — not against your stylist, your salon, or the person who did your hair growing up. Conversations are confidential. Some matters may be referred to or handled with other law firms. No settlement has been announced and no trial has been held; every case depends on its own facts. This page does not diagnose anything. Attorney Advertising.

This page is about a lawsuit — it is legal information, not medical advice, and it does not diagnose anything. Questions about your health belong with your own doctor.

Lawsuits consolidated in federal court in Chicago (MDL 3060) allege that long-term use of chemical hair relaxers is associated with uterine cancer, ovarian cancer, and related conditions. As of October 2026 the cases are in pretrial proceedings; no trial has been held and no settlement has been announced. The allegations have not been proven, and each case depends on its own facts.

Endometrial cancer, uterine cancer, and why both words appear

The endometrium is the lining of the uterus, and cancer that begins there is endometrial cancer — the most common form of uterine cancer. Doctors, pathology reports and cancer registries move between the two terms constantly. So do the court’s orders: the November 13, 2024 memorandum opinion (Dkt. 946) lists “uterine, ovarian, or endometrial cancer” together, and the bellwether damages order of June 2026 refers simply to “the … MDL injury (i.e., ovarian or uterine cancer)” (Dkt. 1944).

For screening purposes the distinction almost never changes the answer. If your records say endometrial adenocarcinoma, endometrioid carcinoma, or cancer of the corpus uteri, you are in the same lane as everyone reading the uterine cancer page. This page exists because that is the word many women were actually given, and searching for the word you were given should not send you somewhere that talks past you. It seems like you may already have been told, by a search result or by someone at a desk, that you were in the wrong place. You were not.

What being a “core injury” means in practice

It means three specific things in the court record, no more and no less.

First, the refiling window. Dkt. 946 preserved, for plaintiffs later diagnosed with uterine, ovarian or endometrial cancer, six months from the date of diagnosis to file — only in the federal MDL 3060 in the Northern District of Illinois, and with a complete Plaintiff Fact Sheet served within ten business days.

Second, the trial track. All ten bellwether trial cases the court selected on April 2, 2026 (Dkt. 1781) come from this group. Bellwether outcomes do not bind anyone else’s case, but they set the terms on which the rest of the litigation is measured.

Third, the pleading history. The same order dismissed with prejudice cancer claims filed after September 14, 2023 by plaintiffs who did not in fact have a cancer diagnosis, and dismissed with prejudice other injuries claimed alongside a withdrawn no-diagnosis cancer claim. Deadlines in this litigation have already been enforced, more than once.

The research behind the endometrial and uterine claims

None of this research existed in any form you would have encountered while you were using these products. For most women the only risk anyone ever named was a scalp burn — that is what the box warned about, and until October 2022 there was nothing else in general circulation to know.

The central study is the NIH-funded Sister Study, published in the Journal of the National Cancer Institute in 2022. It followed 33,947 women aged 35 to 74 who had a uterus at enrollment; over an average of 10.9 years of follow-up, 378 uterine cancer cases were identified. Ever-use of straightening products in the previous twelve months was associated with a higher uterine cancer rate (HR = 1.80, 95% CI = 1.12 to 2.88); frequent use — more than four times in twelve months — carried HR = 2.55 (95% CI = 1.46 to 4.45). NIH put the absolute figures at 1.64 percent of never-users developing uterine cancer by age 70, against 4.05 percent of frequent users.

The Black Women’s Health Study, reported by Boston University in 2023, followed nearly 45,000 Black women without prior cancer for up to 22 years and associated relaxer use more than twice a year, or for more than five years, with a greater than 50 percent increased rate of uterine cancer.

The study authors’ own hypothesis is chemical: parabens, bisphenol A, metals and formaldehyde-releasing compounds in straighteners, described as having endocrine-disrupting properties. A 2018 analysis of 18 products marketed to Black women detected 45 of 66 targeted endocrine disruptors, and found 84 percent of detected chemicals were not on the label. Every figure and citation is laid out in the study evidence ledger.

Study findings and adverse-event reports describe associations; they are not verified causation.

Do you qualify?

Eligibility is decided by a review of your own use history and records, not by a web page. This page will not tell you that you qualify in order to get you into a form, and it does not hand you to a lead broker: some matters may be referred to or handled with other law firms, and you are told which before anything happens.

That last point is the one that quietly ends cases, so it gets checked first. The eligibility page walks through each item. The first step is about two minutes, costs nothing, and asks nothing you have to find first — records are requested for you, with your authorization.

What this page is not

This page is legal information, not medical advice, and it does not diagnose anything. Questions about your health belong with your own doctor.

No hair relaxer settlement has been announced and no one has been paid. Any page that quotes a dollar figure is estimating. What decides the value of a product-liability claim, once there is anything to decide, is diagnosis, treatment, length of use and documentation — the same file a review builds either way.

Consultations are free and confidential, and there is no fee unless there is a recovery. Some matters may be referred to or handled with other law firms.

A claim here is against the companies that made and sold the product — not against a salon, not against whoever applied it, and not against you for having used something sold in every drugstore in the country. Would it be wrong to spend two minutes finding out where you stand? You get an answer either way, including the answer that there is nothing here for you.

Frequently Asked Questions

Cases are handled on a contingent-fee basis: no fee unless there is a recovery. The attorney’s fee is a percentage of the gross recovery, calculated before case expenses are deducted. Case expenses are advanced by the firm and reimbursed to the firm out of the recovery only if there is a recovery. You have no liability for court costs or litigation expenses if there is no recovery, unless a court directs otherwise.